Analysis of the disease management program in the post-covid period: improvement and its further development

2024

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.51582/interconf.19-20.05.2024.036
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The article discusses the importance of improving and developing the Disease Management Program in the post-Covid period. The emphasis is on the need to adapt existing strategies to new challenges arising from the COVID-19 pandemic. The purpose of this study is to evaluate the effectiveness of the post-Covid Disease Management Program, with a view to identifying successful practices and possible improvements to ensure more effective disease control in the wake of the COVID-19 pandemic.